Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark Eliana
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dube Michael P
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Verwiel Frank
Intellia Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Goff Brian
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Goff Brian
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bhanji Muna
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Verwiel Frank
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOODMAN JESSE
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Keresty Georgia
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHASE WILLIAM J
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 10-Q: Quarterly report
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics | DEFA14A: Others
Intellia Therapeutics | ARS: Annual Report to Security Holders
Intellia Therapeutics | DEF 14A: Definitive information statements
Intellia Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dube Michael P
No Data